FDA's Vaccines and Related Biological Products Advisory Committee is scheduled to meet on Friday, Sept. 17, between 8:30 am and 3:45 pm, to discuss Pfizer, Inc. (NYSE: PFE)/BioNTech SE (NASDAQ: BNTX)'s COVID-19 vaccine, Comirnaty, for administration of a third dose, or "booster" dose in individuals 16 years of age and older.